Cargando…
Butyrate Improves Skin/Lung Fibrosis and Intestinal Dysbiosis in Bleomycin-Induced Mouse Models
Systemic sclerosis (SSc) is an autoimmune disorder characterized by fibrosis of the skin and internal organs. Despite several studies on SSc treatments, effective treatments for SSc are still lacking. Since evidence suggests an association between intestinal microbiota and SSc, we focused on butyrat...
Autores principales: | Park, Hee Jin, Jeong, Ok-Yi, Chun, Sung Hak, Cheon, Yun Hong, Kim, Mingyo, Kim, Suhee, Lee, Sang-Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967124/ https://www.ncbi.nlm.nih.gov/pubmed/33803282 http://dx.doi.org/10.3390/ijms22052765 |
Ejemplares similares
-
Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis
por: Roh, Jong Seong, et al.
Publicado: (2021) -
Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
por: Karunaratne, Tennekoon B., et al.
Publicado: (2020) -
Sodium Butyrate Alleviates Mouse Colitis by Regulating Gut Microbiota Dysbiosis
por: Dou, Xiujing, et al.
Publicado: (2020) -
Effects of aging on accompanying intermittent hypoxia in a bleomycin-induced pulmonary fibrosis mouse model
por: Lee, Heayon, et al.
Publicado: (2023) -
Unusual milia-type intradermal tophi in a patient with gout
por: Kim, Mingyo, et al.
Publicado: (2020)